Editorial - The innovation and access to landscape

European Commission, 2014 EU Industrial R&D Investment Scoreboard.

US Food and Drug Administration, “Summary of NDA Approvals and Receipts, 1938-present,” http://www.fda.gov/aboutfda/whatwedo/history/productregulation/summaryofndaapprovalsreceipts1938tothepresent/default.htm.

Pharmaceutical Research and Manufacturers of America (PhRMA), “Medicines in Development,” http://www.phrma.org/innovation/meds-in-development.

US Food and Drug Administration, “Novel drug approvals for 2015,” http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugInnovation/ucm430302.htm.

Nature Reviews Drug Discovery, “The importance of new companies for drug discovery: origins of a decade of new drugs,” http://www.nature.com/nrd/journal/v9/n11/full/nrd3251.html.

2014, IMS Institute for Healthcare Informatics, Understanding the pharmaceutical value chain. http://www.ifpma.org/resource-centre/understanding-the-pharmaceutical-value-chain.

http://www.ifpma.org/resource-centre/ucl-matrix-insight-falsified-medicines-and-the-global-publics-health.

http://www.ich.org/home.html.

http://amrh.org.

http://www.undp.org/content/undp/en/home/sdgoverview/post-2015-development-agenda/goal-3.html.

https://sustainabledevelopment.un.org/content/documents/21252030%20Agenda%20for%20Sustainable%20Development%20web.pdf.

R&D projects to prevent and control neglected conditions - 2014 status report, IFPMA - http://www.ifpma.org.